CASE REPORTS
Magnetic Resonance Urography : A One-stop shop for Pelvic Endometriosis
Paritosh C. Khanna*, Arvind Tiwari*, Ajita Nawale**, Suleman A. Merchant***
We present a new diagnostic approach in the evaluation of difficult female pelvic masses, especially those causing mass effect on the urinary tract. A 35-year-old female patient presenting with pelvic pain was investigated with Ultrasonography (USG), Computed Tomography (CT) and Magnetic Resonance Urography (MRU). It was found that MRU, with its dual advantage scored over both USG and CT in diagnostic accuracy. Endometriomas diagnosed at MRU were later retrieved at surgery and proved at histopathology.
Introduction
MRI is a well established diagnostic modality for assessment of pathologies and masses of the female pelvis. The use of MR urography as a technique to evaluate these masses and their effects on the surrounding pelvic organs is relatively new and is gaining widespread acceptance due to its dual advantage. We present here a unique case in which MRU proved its superiority over other diagnostic modalities.
Case Report
A 35-year-old female patient, Gravida 3, Para 2, Living 2, Abortion 1, presented with dull aching chronic pain in the right iliac fossa (RIF) since two months along with weight loss, dysmenorrhoea and oligomenorrhoea. She also complained of urgency and a sensation of incomplete micturition. Physical examination revealed tenderness in RIF. Per vaginal examination revealed an anteverted uterus deviated towards the left with a mass felt in the right fornix, which was firm, immobile and tender. Routine investigations were normal.
Fig. 1 : Pelvic sonogram showing a hypoechoic lesion with low-level internal echoes, an echogenic mural nodule (upper arrow) and a thick echogenic wall (lower arrow).
US examination (Fig. 1) showed a large, eight centimeter sized cystic mass lesion arising from the right ovary with a few mural nodules and septations at the periphery. Mural nodules measured 5-10 mm in size and the cystic component showed moderate-level internal echoes with mild tenderness suggestive of haemorrhage. The lesion appeared to be adherent to the ovary rather than arising from it. There was evidence of another 2.5 cm sized oval lesion with thick walls in the left adnexa. The pelvicalyceal system and ureter were dilated up to the level of the right adnexal mass. Mild free fluid was noted in pouch of Douglas (POD).
Contrast-enhanced CT scan (Fig. 2) revealed an 8 cm sized cystic lesion with enhancing walls and septae within the lesion arising from the right ovary. The posterior wall of the lesion was thick and irregular, with surrounding fat stranding. Few follicles were noted in the part of the ovary visualized just above the lesion. This lesion was causing mass effect on the bladder (postero-superior aspect) and right ureter with resultant moderate dilatation of right pelvicalyceal system and ureter. Another 4 cm sized similar cystic lesion with thick enhancing walls was noted in the POD, separate from the ovaries. Minimal free fluid was present in the POD. Possibilities included cystic malignant ovarian lesions or cystic lesions of infective etiology. Ca 125 levels, however, were normal.
To further characterize this lesion, Magnetic Resonance Urography (MRU, Figs. 3, 4) was performed after intravenous administration of contrast (low dose i.e. 0.01 mg/kg body weight of gadolinium DTPA) using two-dimensional Fast Low-Angle Shot (2D FLASH) T1-weighted (T1W) coronal sequences at every one minute interval for ten minutes followed by T2W Turbo Spin Echo (TSE) and Fast Imaging in Steady state Precession (FISP) coronal sequences for the ureters and the bladder. A heavily T2 weighted sequence, RARE (Rapid Acquisition with Relaxation Enhancement) was also obtained to obtain static MRU images. Multiple cystic lesions were seen in the pelvis showing heterogenous signal intensities, the largest on the right, appearing hypointense on the FISP coronal images. The right ureter was compressed by this lesion with proximal hydroureteronephrosis. Both kidneys showed prompt excretion of contrast and good function with a normal left kidney and ureter. The possibility of endometriosis was strongly considered due to heterogenous signal intensities seen within the lesion on MRU, suggestive of blood products in various stages of degradation.
Fig. 2 : Contrast-enhanced CT. Hypodense right ovarian lesion with a thick enhancing wall and a hyperdense enhancing mural nodule.
![]()
Fig. 4 : T2 weighted post-contrast MR Urogram depicting a dilated right pelvicalyceal system and ureter, the lower third of which was compressed by the pelvic lesions.
Fig. 3 : T1 weighted pre-contrast MR Urogram depicting heterogenous signal intensity lesions in the pelvis with thick, high signal intensity walls.
Fig. 5 : Post-operative specimen depicting thickened fibrotic walls and irregular, necrotic inner surfaces.At surgery, two masses were removed. Grossly, they were brownish externally with thickened fibrotic walls and irregular, necrotic inner surfaces (Fig. 5). The diagnosis of endometriosis was confirmed pathologically.
Discussion
Endometriosis is the appearance or occurrence of active endometrial tissue at sites other than the endometrial cavity, relatively frequent in females of menstrual age.
Endometriomas have a broad spectrum of sonographic patterns due to evolutionary blood degradation processes. They can be anechoic to hypoechoic adnexal masses with low-level internal echoes having hyperechoic wall foci and wall nodularity with acoustic enhancement. They can also appear to be multiloculated cystic masses with poor vascularity. They present with a diagnostic dilemma as they simulate the appearance of haemorrhagic ovarian cysts, tubo-ovarian abscesses, cystadenomas, cystadenocarcinomas or even cystic teratomas.1-4 Haemorrhagic cysts are discovered because intracystic haemorrhage is acutely symptomatic and shows fibrinous strands and retracting clots whereas endometriomas are persistent lesions and are rarely seen with fresh haemorrhage. A mass with low-level internal echoes, hyperechoic wall foci, without neoplastic features and with multilocularity is 64 times more likely to represent an endometrioma than another adnexal mass.2 The hyperechoic wall foci may contain cholesterol, perhaps from the breakdown of cell membranes. Despite the considerable overlap in the morphologic patterns of different pelvic masses, a characteristic sonographic appearance frequently allows at least a narrow differential diagnosis, particularly when imaging findings are coupled with sufficient clinical data.3, 5
The finding of hyperdense foci on CT (attenuation: 90 - 140 Hounsfield Units) next to the inner border of the lesion is suggestive of endometrioma and should help in distinguishing from other pelvic masses. CT allows identification of the extent and relationship of the mass to the neighbouring structures. Discrete adnexal endometriosis appears as thick walled cystic masses or as simple cyst(s). CT plays an important role in demonstrating bowel wall involvement and pelvic side-wall lesions.6
MRI is a very promising modality for the evaluation of the female pelvis and unlike CT, carries no radiation burden for the patient. MRU, a technical modification evaluates the proximal urinary tract in addition. Some workers have recommended the use of protocols which include T1W sequences with fat suppression and/or without contrast administration.7 High accuracy is obtained due to multiplanar imaging and the ability to detect blood degradation products. It also provides information about site and size of extra-peritoneal lesions.8 For our patient we ran T1W sequences (FLASH) with non-nephrotoxic gadolinium as contrast (to gauge renal function) and T2W sequences (TSE, FISP) including a heavily weighted T2 sequence (RARE). This afforded excellent functional-anatomical correlation as regards renal status at the same time providing sufficient pathological information.
Conclusion
Judging by careful correlation between the surgical and pathologic specimens and radiological investigations, we found US to be extremely accurate in determining the size, shape and location of the endometriomas. However, we had to strongly rely upon MR urography to characterize these pelvic masses and to gain an insight into the secondary obstructive effects they were producing on the urinary tract. In addition, MRU with its large field of view proved useful to corroborate the ultrasound findings and to completely replace CT in such patients. We thus recommend this technique (MR urography) in such problem cases where ultrasound is unable to provide complete answers and CT adds no conclusive diagnostic information.
References
1. Sandler MA, Karo JJ. The spectrum of ultrasonic findings in endometriosis. Radiology 1978; 127(1): 229-31.
2. Patel MD, Feldstein VA, Chen DC, Lipson SD, Filly RA. Endometriomas: diagnostic performance of US. Radiology 2000; 215(1): 305-7.
3. Fried AM, Kenney CM 3rd, Stigers KB, Kacki MH, Buckley SL. Benign pelvic masses: sonographic spectrum. Radiographics 1996; 16(2): 321-34.
4. Athey PA, Diment DD. The spectrum of sonographic findings in endometriomas. J Ultrasound Med 1989; 8 (9): 487-91.
5. Kupfer MC, Schwimer SR, Lebovic J. Transvaginal sonographic appearance of endometriomata: spectrum of findings. J Ultrasound Med 1992; 11(4): 129-33.
6. Fishman EK, Scatarige JC, Saksouk FA, Rosenshein NB, Siegelman SS. Computed tomography of endometriosis. J Comput Assist Tomogr 1983; 7 (2) : 257-64.
7. L. Manganaro, L. Ballesio, E. Notarianni, C. De Felice, C. Andreoli; Rome I/T. Endometriosis and MRI: Capabilities and pitfalls with laparoscopic correlations. ECR 2001, Presentation C-0368.
8. Siegelman ES, Outwater E, Wang T, Mitchell DG. Solid pelvic masses caused by endometriosis: MR imaging features. AJR Am J Roentgenol 1994; 163 (2) : 357-61.
CORTICOSTEROID INJECTION IMPROVES KNEE PAIN
Intra-articular corticosteroid injections improve symptoms of osteoarthritis of the knee in the short term, and may work even after six months. Arrol and Goodyear-Smith reviewed 10 randomised trials and found that intra-articular steroid injections improved symptoms at one to two weeks (relative risk 1.66). Only one study of good quality had results at 16-24 weeks; it showed a benefit from treatment. No major harms were found, and the only study investigating potential loss of joint space found no harm after steroid injection. Higher doses of corticosteroids may be needed to obtain long term benefits, the authors say.
BMJ, 2004; 328 : 869.
*4th Year Resident; **Lecturer; ***Professor and Head, Department of Radiology, LTMG Hospital, Sion, Mumbai 400 022.
![]() |